Catheter replacement in continuous arteriovenous hemodiafiltration: The balance between infectious and mechanical complications*

ObjectiveTo assess the optimal moment of central vascular catheter replacement balancing infectious and mechanical complications in continuous renal replacement therapies in critically ill patients with acute renal failure. MethodsProspective sequential trial with historical controls to compare liberal catheter replacement when clinically indicated with routine catheter replacement every 5 days in consecutive patients treated by continuous arteriovenous hemodiafiltration in a level I secondary referral intensive care unit of a university-affiliated teaching hospital. Intention-to-treat analysis. Measurements and Main ResultsTwenty-two patients underwent catheter replacement when clinically indicated (group II), and 21 patients served as historical controls (group I). The groups were comparable for sex, age, Acute Physiology and Chronic Health Evaluation II scores, comorbidity, and creatinin and urea levels at the start of continuous arteriovenous hemodiafiltration. In group I, 71 catheters were used for 346 treatment days, and in group II, 68 catheters were used for 495 treatment days. The mean duration of catheterization was 4.9 ± 2.0 days vs. 7.3 ± 4.5 days, respectively (Student’s t-test p < .001). There was no significant difference between the incidence of colonization of catheters (46.8% in group I vs. 39.1% in group II; chi-square p = .35) In group I, bacteremia and catheter sepsis occurred in two patients, whereas this did not occur in group II. The occurrence of mechanical complications was comparable in both groups (15.5% in group I vs. 19.1% in group II). There were significantly more mechanical complications with arterial vs. venous catheters (17 vs. 7; chi-square p = .027). ConclusionWhen catheters were changed as clinically indicated, they remained significantly longer in situ vs. being replaced routinely every 5 days; infectious and mechanical complications were comparable. The incidence of catheter sepsis was low (2.2%), and no prosthesis infection occurred. Catheter replacement when clinically indicated seems to be as safe as routine replacement every 5 days.

[1]  R. Spencer,et al.  Novel methods for the prevention of infection of intravascular devices. , 1999, The Journal of hospital infection.

[2]  B. Souweine,et al.  Dialysis and central venous catheter infections in critically ill patients: results of a prospective study. , 1999, Critical care medicine.

[3]  A. Cyna,et al.  Routine replacement of central venous catheters: telephone survey of intensive care units in mainland Britain , 1998, BMJ.

[4]  M. O'Leary,et al.  Central venous catheters—time for a change? , 1998, BMJ.

[5]  D. Cook,et al.  Central venous catheter replacement strategies: a systematic review of the literature. , 1997, Critical care medicine.

[6]  S. Venkataraman,et al.  Femoral Vascular Catheterization in Critically Ill Infants and Children , 1997, Clinical pediatrics.

[7]  M. Pearson Guideline for Prevention of Intravascular-Device–Related Infections , 1996, Infection Control &#x0026; Hospital Epidemiology.

[8]  J. Almaraz,et al.  Departmental role and scope in infection control: use of a template that meets Joint Commission requirements. , 1996, American journal of infection control.

[9]  R. Bellomo,et al.  A prospective comparative study of continuous arteriovenous hemodiafiltration and continuous venovenous hemodiafiltration in critically ill patients. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  G. Bodey,et al.  Infectious complications of indwelling vascular catheters. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  N. Nahman,et al.  Continuous arteriovenous hemofiltration. , 1990, The Medical clinics of North America.

[12]  T. Clemmer,et al.  The risk of infection related to radial vs femoral sites for arterial catheterization , 1983, Critical care medicine.

[13]  S. Vas,et al.  CHANGING SUBCLAVIAN HAEMODIALYSIS CANNULAS TO REDUCE INFECTION , 1981, The Lancet.

[14]  M. Pearson Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections : an overview. The Hospital Infection Control Practices Advisory Committee , 1996 .

[15]  J. Kaufman Complications and failures of subclavian-vein catheterization. , 1995, The New England journal of medicine.

[16]  H. Bruining,et al.  High-risk surgical acute renal failure treated by continuous arteriovenous hemodiafiltration: metabolic control and outcome in sixty patients. , 1995, Nephron.

[17]  M. Vos,et al.  The use of continuous arteriovenous hemodiafiltration in multiple organ failure patients. , 1991, Applied cardiopulmonary pathophysiology : ACP.

[18]  L. Goldman,et al.  The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy. , 1989, Journal of clinical epidemiology.

[19]  T. Cowell,et al.  THE AMERICAN AND HIS DIET. , 1964, Lancet.